OClawVPS.com
Phreesia
Edit

Phreesia

http://www.phreesia.com/
Last activity: 08.09.2025
Active
Categories: CareContentFinTechHealthTechInformationInsurTechMedTechOptimizePlatformTime
Leading healthcare organizations choose Phreesia to revolutionize their point of service. Regardless of size, specialty or demographics, today’s healthcare systems face the same challenges: escalating demands, rising costs and increasing patient responsibility. Phreesia’s innovative point-of-service platform—including patient self-service and mobile applications—resolves these issues by driving efficiency and profitability throughout your organization. Your patients expect a seamless, automated experience from other industries. Why should your front office be any different?
Likes
995
Followers
26.04K
Website visits
84.9K /mo.
Mentions
45
Location: United States, North Carolina, Raleigh
Employees: 1001-5000
Phone: +1 888-654-7473
Total raised: $63.6M
Founded date: 2005

Investors 7

Funding Rounds 4

DateSeriesAmountInvestors
23.10.2014-$30M-
28.09.2010Series D$6M-
26.05.2010Series D$16M-
17.02.2009-$11.6M-

Mentions in press and media 45

DateTitleDescription
08.09.2025Phreesia to Acquire AccessOne for $160M to Expand Healthcare Payment SolutionsWhat You Should Know: – Phreesia, Inc., a company specializing in patient activation, has entered into a definitive agreement to acquire AccessOne Parent Holdings, Inc., a portfolio company of Frontier Growth. – The all-cash transaction is ...
27.01.2025Allara Health garners $26M for women's health platformPhoto: filadendron/Getty Images Virtual women's healthcare platform Allara Health scored $26 million in Series B funding, bringing its total raise to $38.5 million. Index Ventures led the round with participation from existing investor GV (...
21.11.2024The Digital Frontier: How Software Companies and Automakers are Shaping TomorrowIn the fast-paced world of technology, software companies and automakers are at the forefront of innovation. They are not just adapting; they are transforming. The Software Report recently unveiled its Top 100 Software Companies of 2024, sh...
20.11.2024The Software Report Announces The Top 100 Software Companies of 2024We are pleased to announce The Software Report's fifth annual Top 100 Software Companies. NEW YORK, Nov. 20, 2024 /PRNewswire-PRWeb/ -- We are pleased to announce The Software Report's fifth annual Top 100 Software Companies. As one of the ...
10.06.2024Nearly Half of PAs Find “Mid-Level Provider” Offensive, Survey ShowsWhat You Should Know: – A recent survey by Barton Associates investigated how physician assistants (PAs) feel about the term “mid-level provider.” The term has been discouraged by the American Academy of Physician Associates (AAPA) due to c...
10.06.2024Nearly 70% of High-Risk Patients Unaware of Chronic Kidney Disease Risk, Study FindsWhat You Should Know: – A new study by Phreesia and the National Kidney Foundation (NKF) reveals a troubling gap in awareness of chronic kidney disease (CKD) among high-risk patients. Published in The American Journal of Accountable Care, t...
15.08.2023Phreesia Acquires Access eFormsPhreesia, a Wilmington, DE-based company which specializes in patient intake, outreach and activation, acquired Access eForms, an electronic forms management and automation provider. The amount of the deal was not disclosed. With the acquis...
17.07.2023Phreesia Buys MediFindPhreesia, a Wilmington, DE-based company which specializes in patient intake, outreach and activation, acquired Comsort, Inc. d/b/a MediFind, a Baltimore, MD- and Philadelphia, PA-based health technology company. The amount of the deal was ...
17.07.2023Phreesia Acquires MediFind, Reinforcing its Commitment to Patient-Centered Care and Expanding its Offerings to ConsumersPhreesia, a leader in patient intake, outreach and activation, is pleased to announce it has acquired Comsort, Inc. d/b/a MediFind (“MediFind”), a health technology company that uses advanced analytics to help patients—especially those with...
23.11.2021Drag­on­fly gets Mer­ck on sec­ond TriN­KET can­di­date since 2018 col­lab; Chi­nese eye gene ther­a­py de­vel­op­er nabs $60MDrag­on­fly Ther­a­peu­tics is do­ing bet­ter and bet­ter in get­ting Big Phar­ma on its TriN­KET plat­form. First Cel­gene, then BMS, and now Mer­ck — again. Af­ter Mer­ck li­censed its first can­di­date from the plat­form back in No­vem­b...
Show more

Reviews 0

Sign up to leave a review

Sign up Log In